Abstract
The present study was designed to determine the effects ofp-chlorophenylalanine (PCPA) andp-chloroamphetamine (PCA) administration on (1) the levels of serotonin (5-hydroxytryptamine, 5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) in rat brain, (2) the sensitivity of LSD-trained rats to the stimulus effects of LSD, and (3) the maximal levels of 5-HT2A and 5-HT2C receptor mediated phosphoinositide (PI) hydrolysis in rat brain. PCA and PCPA both produced a significant depletion of whole brain 5-HT and 5-HIAA concentrations. The depletion of serotonin with PCPA, but not PCA, resulted in supersensitivity of LSD-trained subjects to the stimulus effects of LSD. Neither PCPA nor PCA treatment altered the maximal level of 5-HT2A receptor-mediated PI hydrolysis. However, PCPA, but not PCA, treatment resulted in a significant upregulation (46%,P<0.05) of the maximal level of 5-HT2C receptor mediated PI hydrolysis. These data suggest that upregulation of the 5-HT2C receptor mediates the supersensitivity to LSD discriminative stimulus which follows the depletion of central nervous system serotonin by PCPA.
Similar content being viewed by others
References
Aghajanian G, Foote WE, Sheard MH (1968) Lysergic acid diethylamide: Sensitive neuronal units in the midbrain raphe. Science 161:706–708
Appel JB, Freedman DX (1964) Chemically-induced alterations in the behavioral effects of LSD-25. Biochem Pharmacol 13:861–869
Appel JB, Lovell RA, Freedman DX (1970a) Alterations in the behavioral effects of lysergic acid diethylamide by pretreatment withp-chlorophenylalanine and alpha-methyl-p-tyrosine. Psychopharmacologia 18:387–406
Appel JB, Sheard MH, Freedman DX (1970b) Alterations in the behavioral effects of LSD by midbrain raphe lesions. Commun Behav Biol 5:237–241
Appel JB, Joseph JA, Utsey E, Hernardez LL, Boggan WO (1977) Sensitivity to psychoactive drugs and the serotonergic neuronal system. Commun Psychopharmacol 1:541–551
Appel JB, White FJ, Holohean AM (1982) Analyzing mechanisms of hallucinogenic drug action with drug discrimination procedures. Neurosci Biobehav Rev 6:529–536
Baumgarten HG (1973) Evaluation of the effects of 5,7-DHT on serotonin and CA neurons in the rat CNS. Acta Physiol Scand Suppl 391:3–9
Berendsen HHG, Broekkamp CLE, Van Delft AML (1991) Depletion of brain serotonin differentially affects behaviors induced by 5-HT1A, 5-HT1C and 5-HT2 receptor activation in rats. Behav Neural Biol 55:214–226
Berridge MJ, Downes PC, Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. J Biochem 206:587–595
Bertilsson L, Koslow SH, Costa E (1975) 5-hydroxytryptamine depletion in mesencephalic nuclei of rat brain following a single injection ofp-chloroamphetamine. Brain Res 91:348–350
Bjorkland A, Baumgarten HB, Rensch A (1975) 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J Neurochem 24:833–835
Blackshear MA, Steranka LR, Sanders-Bush E (1981) Multiple serotonin receptors: regional distribution and effect of raphe lesions. Eur J Pharmacol 76:325–334
Browne RG, Ho BT (1975) Role of serotonin in the discriminative stimulus properties of mescaline. Pharmacol Biochem Behav 3:429–435
Burris KD, Breeding M, Sanders-Bush E (1991) (+)Lysergic acid diethylamide, but not its non-hallucinogenic congeners, is a potent serotonin 5-HT1C receptor agonist. J Pharmacol Exp Ther 258:891–896
Callahan PM, Cunningham KA (1994) Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties ofm-chlorophenylpiperazine. Eur J Pharmacol 257:27–38
Cameron OG, Appel JB (1973) A behavioral and pharmacological analysis of some of the discriminable properties ofd-LSD in rats. Psychopharmacologia 33:117–134
Colpaert FC, Niemegeers CJE, Kuyps JJMD, Janssen PAJ (1977) Narcotic cue and narcotic state: differential involvement in brain 5-hydroxytryptamine. Neuropharmacology 16:65–70
Commissaris R, Lyness WH, Rech RH, Moore KE (1979) Central aminergic neuronal systems and the behavioral effects of hallucinogens. Soc Neurosci Abstr 5:2190
Conn PJ, Sanders-Bush E (1986) Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT2 binding site. J Neurosci 6:3669–3675
Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5- HT1C) receptors. J Pharmacol Exp Ther 242:552–557
Conn PJ, Janowsky A, Sanders-Bush E (1987) Denervation supersensitivity of the 5-HT1C receptors in rat choroid plexus. Brain Res 400:396–398
Fiorella D, Rabin RA, Winter JC (1995a) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects ofm-chlorophenylpiperazine. Psychopharmacology 119:222–230
Fiorella D, Palumbo PA, Rabin RA, Winter JC (1995b) The time dependent stimulus effects of (−)2,5-dimethoxy-4-methylamphetamine: implications for drug-induced stimulus controls as a method for the study of hallucinogenic drugs. Psychopharmacology 119:239–245
Fiorella D, Rabin RA, Winter JC (1995c) The role of the 5-HT2A and 5- HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis. Psychopharmacology (in press)
Fiorella D, Rabin RA, Winter JC (1995d) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: Reassessment of LSD false positives. Psychopharmacology (in press)
Freedman DX (1961) Effects of LSD-25 on brain serotonin. J Pharmacol Exp Ther 134:160–166
Fuxe K, Ogren S, Agnati LF, Jonsson G, Gustafsson J (1978) 5,7-Dihydroxytryptamine as a tool to study the functional role of central 5-hydroxytryptamine neurons. Ann NY Acad Sci 305L:346–369
Glennon RA (1990) Do hallucinogens act as 5-HT2 agonists or antagonists? Neuropsychopharmacology 3:509–517
Glennon RA (1994) Classical hallucinogens: an introductory overview. In: Lin GC, Glennon RA (eds) Hallucinogens, an update. NIDA Research Monograph 146, Washington, DC, pp 4–32
Glennon RA, Dukat M (1991) Serotonin receptors and their ligands: a lack of selective agents. Pharmacol Biochem Behav 40:1009–1016
Glennon RA, Hauck AE (1985) Mechanistic studies on DOM as a discriminative stimulus. Pharmacol Biochem Behav 23:937–941
Glennon RA, Darmani NA, Martin BR (1991) Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents. Life Sci 48:2493–2498
Hall H, Wedel I (1985) The effects of manipulation of presynaptic 5-HT nerve terminals on postsynaptic 5-HT1 and 5-HT2 binding sites of the rat brain. J Neural Transm 64:129–143
Harvey JA, McMaster SE, Yunger LM (1975)p-Chloroamphetamine: selective neurotoxic action in brain. Science 187:841–843
Ismaiel AM, De Los Angeles J, Titeler M, Ingher S, Glennon RA (1993) Antagonism of the 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist. J Med Chem 36:2519–2525
Jacobs BL (1987) How hallucinogenic drugs work. Am Sci 75:386–392
Jarbe TUC, Johansson JO, Henriksson DG (1975) Drug discrimination in rats: the effects of phencyclidine and ditran. Psychopharmacologia 42:33–39
Jequier E, Lovenberg W, Sjoerdsma A (1967) Tryptophan hydroxylase inhibition: the mechanism by whichp-chlorophenylalanine depletes rat brain serotonin. Mol Pharmacol 3:274–278
Joseph JA, Appel JB (1976) Alterations in the behavioral effects of LSD by motivational and neurohumoral variables. Pharmacol Biochem Behav 5:35–37
Joseph JA, Appel JB (1977) Behavioral sensitivity of LSD: dependency upon the pattern of central 5-HT depletion. Pharmacol Biochem Behav 6:499–504
Kalkman HO (1990) Discriminative stimulus properties of 8-OH-DPAT in rats are not altered by pretreatment withpara-chlorophenylalanine. Psychopharmacology 101:39–42
Koe BK, Weisman A (1966)p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 154:499–516
Kohler C, Ross SB, Sebro B, Ogren SO (1978) Long-term biochemical and behavioral effects ofp-chloroamphetamine in the rat. Ann NY Acad Sci 305:645–663
Leysen (1990) Gaps and peculiarities in 5-HT2 receptor studies. Neuropsychopharmacology 3:361–369
Lorrain DS, Hull EM (1993) Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuro Report 5:87–89
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Lucki I (1992) 5-HT1 receptors and behavior. Neurosci Biobehav Rev 16:83–93
Lucki I, Ward HR, Frazer A (1989) Effect of 1-(m-chlorophenyl) piperazine and 1-(m-trifluoromethylphenyl) piperazine on locomotor activity. J pharmacol Exp Ther 249:155–164
Meek JL (1978) Studies of serotonin neurotoxins in discrete brain nuclei. Ann NY Acad Sci 305:190–196
Neckers LH, Bertilsson L, Koslow SH, Meek JL (1976) Reduction of tryptophan hydroxylase activity and 5-hydroxytryptamine concentrations in certain rat brain nuclei afterp-chloroamphetamine. J Pharmacol Exp Ther 196:333–338
Pranzatelli MR (1990) Neonatal 5,7-DHT lesions upregulate (3H)mesulergine-labelled spinal 5-HT1C binding sites in the rat. Brain Res Bull 25:151–153
Quick M, Azmita E (1983) Selective destruction of serotonergic fibers of the fornix-fimbria and cingulum bundle increases 5HT1, but not 5HT2 receptors in rat midbrain. Eur J Pharmacol 90:377–384
Resnick O, Krus DM, Raskin M (1965) Accentuation of the psychological effects of LSD-25 in normal subjects treated with reserpine. Life Sci 4:1433–7
Sahin-Erdemli I, Schoeffter P, Hoyer D (1991) Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus. Naunyn-Schmiedeberg's Arch Pharmacol 244:137–142
Sanders-Bush E, Breeding M (1988) Putative selective 5-HT2 receptor antagonists block serotonin 5-HT1C receptors. J Pharmacol Exp Ther 247:169–173
Sanders-Bush E, Burris KD, Knoth K (1988) Lysergic acid diethylamide and 2,5-dimethoxy-4-methamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J Pharmacol Exp Ther 246:924–928
Schechter MD (1991) Effect of serotonin depletion byp-chlorophenylalanine upon discriminative behaviors. Gen Pharmacol 22:889–893
Schechter MD, Rosecrans JA (1972) Nicotine as a discriminative stimulus in rats depleted of norepinephrine or 5-hydroxytryptamine. Psychopharmacologia 24:417–429
Schreiber R, Brocco M, Millan MJ (1994) Blockade of the discriminative stimulus effects of DOI and MDL 100,907 and the “atypical” antipsychotics, clozapine and risperidone. Eur J Pharmacol 264:99–102
Titeler M, Lyon RA, Glennon RA (1988) Radioligand binding evidence implicates the brain 5-HT2 receptors as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94:213–216
Van Wijngaarden I, Tulp MTM, Soudijin W (1990) The concept of selectivity in 5-HT research. Eur J Pharmacol 188:301–312
White FJ, Simmons MA, West KB, Holohean AM, Appel JB (1980) The effect of serotonin depletion on the discriminability of LSD. Pharmacol Biochem Behav 13:569–574
Winter JC (1994) The stimulus effects of serotonergic hallucinogens in animals. In: Lin GC, Glennon RA (eds) Hallucinogens, an update. NIDA Research Monograph 146, Washington, DC, pp 157–182
Winter JC, Rabin RA (1993) The stimulus effects ofm-chlorophenylpiperazine in the rat. Pharmacol Biochem Behav 45:221–225
Author information
Authors and Affiliations
Additional information
This study was supported in part by US Public Health Service grant DA 03385 (J.C.W., R.A.R.), by National Research Service Award MH 10567 (D.F.), and by a fellowship from Schering-Plough Research Institute (D.F.). Animals used in these studies were maintained in accordance with the “Guide for Care and Use of Laboratory Animals” of the Institute of Laboratory Animal Resources, National Research Council.
Rights and permissions
About this article
Cite this article
Fiorella, D., Helsley, S., Lorrain, D.S. et al. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs III: the mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion. Psychopharmacology 121, 364–372 (1995). https://doi.org/10.1007/BF02246076
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246076